Lipoxygenase inhibition: The neglected frontier for regulating chronic inflammation and pain

Whitehouse, M. W. and Rainsford, K. (2006) Lipoxygenase inhibition: The neglected frontier for regulating chronic inflammation and pain. Inflammopharmacology, 14 3-4: 99-102. doi:10.1007/s10787-006-1523-7


Author Whitehouse, M. W.
Rainsford, K.
Title Lipoxygenase inhibition: The neglected frontier for regulating chronic inflammation and pain
Journal name Inflammopharmacology   Check publisher's open access policy
ISSN 0925-4692
Publication date 2006-08-01
Sub-type Article (original research)
DOI 10.1007/s10787-006-1523-7
Open Access Status Not Open Access
Volume 14
Issue 3-4
Start page 99
End page 102
Total pages 4
Place of publication Basel, Switzerland
Publisher Birkhauser
Language eng
Subject CX
320503 Clinical Pharmacology and Therapeutics
730305 Diagnostic methods
1115 Pharmacology and Pharmaceutical Sciences
Keyword Emu oil(s)
Lyprinol®
5-lipoxygenase
Corticosteroid
‘Steroid-sparing’
Synergy
Q-Index Code CX

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 3 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 15 Aug 2007, 19:55:13 EST